MainStreet Investment Advisors LLC purchased a new stake in CME Group (NASDAQ:CME) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 16,959 shares of the financial services provider’s stock, valued at approximately $2,477,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Comerica Bank boosted its stake in shares of CME Group by 0.4% in the fourth quarter. Comerica Bank now owns 84,159 shares of the financial services provider’s stock valued at $13,044,000 after buying an additional 313 shares during the period. Daiwa Securities Group Inc. lifted its stake in CME Group by 2.5% during the fourth quarter. Daiwa Securities Group Inc. now owns 14,590 shares of the financial services provider’s stock worth $2,131,000 after purchasing an additional 362 shares during the last quarter. ARGI Investment Services LLC lifted its stake in CME Group by 6.4% during the third quarter. ARGI Investment Services LLC now owns 6,326 shares of the financial services provider’s stock worth $856,000 after purchasing an additional 378 shares during the last quarter. Oppenheimer & Co. Inc. lifted its stake in CME Group by 1.0% during the fourth quarter. Oppenheimer & Co. Inc. now owns 47,233 shares of the financial services provider’s stock worth $6,898,000 after purchasing an additional 447 shares during the last quarter. Finally, Everence Capital Management Inc. lifted its stake in CME Group by 7.0% during the fourth quarter. Everence Capital Management Inc. now owns 7,563 shares of the financial services provider’s stock worth $1,105,000 after purchasing an additional 498 shares during the last quarter. Institutional investors and hedge funds own 83.11% of the company’s stock.
In other news, insider Derek Sammann sold 2,400 shares of the business’s stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $161.66, for a total transaction of $387,984.00. Following the completion of the transaction, the insider now directly owns 40,153 shares in the company, valued at approximately $6,491,133.98. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Hilda Harris Piell sold 3,299 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $163.52, for a total transaction of $539,452.48. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 40,699 shares of company stock valued at $6,266,062. 0.57% of the stock is currently owned by company insiders.
Shares of NASDAQ CME opened at $158.26 on Friday. CME Group has a fifty-two week low of $114.82 and a fifty-two week high of $171.71. The stock has a market capitalization of $55,479.36, a P/E ratio of 33.18, a price-to-earnings-growth ratio of 2.25 and a beta of 0.56. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.10.
CME Group (NASDAQ:CME) last posted its earnings results on Thursday, February 1st. The financial services provider reported $1.12 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.10 by $0.02. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The firm had revenue of $900.00 million for the quarter, compared to analysts’ expectations of $886.85 million. During the same quarter last year, the firm earned $1.14 EPS. The company’s quarterly revenue was down 1.4% compared to the same quarter last year. sell-side analysts expect that CME Group will post 6.89 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Monday, March 26th. Stockholders of record on Friday, March 9th were paid a dividend of $0.70 per share. The ex-dividend date was Thursday, March 8th. This represents a $2.80 annualized dividend and a dividend yield of 1.77%. This is a positive change from CME Group’s previous quarterly dividend of $0.66. CME Group’s dividend payout ratio (DPR) is presently 58.70%.
Several equities research analysts have weighed in on the company. Zacks Investment Research upgraded CME Group from a “hold” rating to a “buy” rating and set a $180.00 target price for the company in a research note on Friday. Barclays increased their price target on CME Group from $170.00 to $175.00 and gave the company an “overweight” rating in a research note on Friday, February 2nd. Sandler O’Neill reiterated a “buy” rating and issued a $175.00 price target on shares of CME Group in a research note on Friday, February 2nd. BidaskClub upgraded CME Group from a “buy” rating to a “strong-buy” rating in a report on Tuesday, March 27th. Finally, Deutsche Bank increased their price objective on CME Group from $185.00 to $197.00 and gave the company a “buy” rating in a report on Friday. Three research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. CME Group has an average rating of “Buy” and an average target price of $163.69.
TRADEMARK VIOLATION NOTICE: “MainStreet Investment Advisors LLC Acquires New Position in CME Group (CME)” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece on another site, it was illegally stolen and reposted in violation of international copyright and trademark law. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/08/16959-shares-in-cme-group-inc-cme-purchased-by-mainstreet-investment-advisors-llc.html.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.